Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q2 2023 Ophthalmology Update

Skip to the end of the Expertise Menu

Q2 2023 Ophthalmology Update

The ophthalmology sector continues to show resilience in the face of macroeconomic conditions that have slowed M&A activity across other industries and sectors. While PE-backed platforms have pulled back M&A efforts, others continue to be acquisitive, especially for practices in attractive markets where there may be significant synergy potential and value creation opportunities. Provident expects deal flow to remain strong moving into the back half of the year as debt markets start to settle and the lending environment softens.

To print and download the full Ophthalmology Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/07/Q2-2023-Newsletter-Package_Ophthalmology.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]